http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0513811-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f46ae8a522d204f38a338161d0294316
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40765ca9a78b54a8a76f781d159ad145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5d5bb9b9a6d998b72b154ceb1895a3f5
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00
filingDate 2005-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b5b2f0803362bb559404827b1d43c67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_080b2f27ee88d14e8ca74734b527e75c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e33afc9705503746f26bd1cbeac37ed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ee786e059514ea0d1ebc4d72131b0cb
publicationDate 2008-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-PI0513811-A
titleOfInvention imidazo [4,5-d] pyrimidines, their uses and processes of preparation
abstract IMIDAZO ยข 4,5-D! PYRIMIDINES, ITS USES AND PREPARATION PROCESSES. The present invention relates to pharmaceutical compositions for the treatment of prevention of viral infections comprising as an active ingredient at least one imidazo [4,5-c]. pyrimidine having the general formula (A), wherein the substituents are described in the specification. The invention also relates to processes for the preparation of compounds according to the invention having the general formula mentioned above, their pharmaceutically acceptable formulations and their use as a medicament or for treating or preventing viral infections.
priorityDate 2004-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559203
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1044
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410062813

Total number of triples: 31.